Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda - Quiz - MDSpire

Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda

New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included

  • April 9, 2026

  • 2 min

Share

Original Source(s)

Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda

  • April 9, 2026

Related Content

Potential clinical value of circulating tumor cells in predicting progression for atypical teratoid rhabdoid tumor in young children

Effective Treatment of Hemophagocytic Lymphohistiocytosis Linked to Scrub Typhus Using Doxycycline and Immunomodulatory Therapy: A Case Study

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis